Neural cell adhesion molecule (CD56)-positive acute myelogenous leukemia and myelodysplastic and myeloproliferative syndromes

American Journal of Clinical Pathology

Volumn 107, Issue 6, 1997, Pages 653-660

  Mann, Karen P ^a   DeCastro, Carlos M ^a   Liu, Jane ^a   Moore, Joseph O ^a   Bigner, Sandra H ^a   Traweek, S Thomas ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Acute myelogenous leukemia; CD56; Leukemia; Myelodysplastic syndrome; Neural cell adhesion molecule

Indexed keywords

CD56 ANTIGEN; NERVE CELL ADHESION MOLECULE;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BLAST CELL; CANCER SURVIVAL; CELL DIFFERENTIATION; CYTOGENETICS; GENE REARRANGEMENT; GENETIC LINKAGE; HUMAN; HUMAN CELL; KILLER CELL; LYMPHOID CELL; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; PROGNOSIS; REMISSION;

EID: 0030948676     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/107.6.653     Document Type: Article

References (37)

1. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the acute leukaemias: French-American-British Cooperative Group. Br J Haematol. 1976;33:451-458.
2. Bennett JM, Catovsky D, Daniel MT, et al, The French-American-British (FAB) Cooperative Group: proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 1982;51:189-199.
3. Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French-American-British Cooperative Group. Ann Intern Med. 1985;103:626-629.
4. Bennett JM, Catovsky D, Daniel MT, et al. Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7): a report of the French-American-British Cooperative Group. Ann Intern Med. 1985;103:460-462.
5. Bennett JM, Catovsky D, Daniel MT, et al. French-American-British (FAB) Cooperative Group: proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO). Br J Haematol. 1991;78:325-329.
6. Domer PH, Fakharzadeh SS, Chen C-S, et al. Acute mixed-lineage leukemia t(4;11)(q21;q23) generates an MLL-AF4 fusion product. Proc Natl Acad Sci USA. 1993;90:7884-7888.
7. Thirman MJ, Gill HJ, Burnett RC, et al. Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. N Engl J Med. 1993;329:909-914.
8. Griffin JD, Hercend T, Beveridge R, Schlossman SF. Characterization of an antigen expressed by human natural killer cells. J Immunol. 1983;130:2947-2951.
9. Hercend T, Griffin JD, Bensussan A, et al. Generation of monoclonal antibodies to a human natural killer clone. J Clin Invest. 1985;75:932-943.
10. Lanier LL, Testi R, Bindl J, Phillips JH. Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule. J Exp Med. 1989;169:2233-2238.
11. Kern WF, Spier CM, Hanneman EH, et al. Neural cell adhesion molecule-positive peripheral T-cell lymphoma: a rare variant with a propensity for unusual sites of involvement. Blood. 1992;79:2431-2432.
12. Wong KF, Chan JKC, Ng CS, et al. CD56 (NKH1)-positive hematolymphoid malignancies: an aggressive neoplasm featuring frequent cutaneous/mucosal involvement, cytoplasmic azurophilic granules, and angiocentricity. Hum Pathol. 1992;23:798-804.
13. Kanavaros P, Lescs M-C, Brière J, et al. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood. 1993;81:2688-2695.
14. Suzumiya J, Takeshita M, Kimura N, et al. Expression of adult and fetal natural killer cell markers in sinonasal lymphomas. Blood. 1994;83:2255-2260.
15. Van Camp B, Durie BGM, Spier C, et al. Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1; Leu-19). Blood. 1990;76:377-382.
16. Drach J, Gattringer C, Huber H. Expression of the neural cell adhesion molecule (CD56) by human myeloma cells. Clin Exp Immunol. 1991;83:418-422.
17. Barker HF, Ball J, Drew M, et al. The role of adhesion molecules in multiple myeloma. Leuk Lymphoma. 1992;8:189-196.
18. + myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3. Blood. 1994;84:244-255.
19. + acute monoblastic leukemia. Am J Hematol. 1990;34:228-229.
20. Ikushima S, Yoshihara T, Matsumera T, et al. Expression of CD56/NCAM on hematopoetic malignant cells: a useful marker for acute monocytic and megakaryocytic leukemias. Int J Hematol. 1991;54:395-403.
21. Yumura-Yagi K, Hara J, Kurahashi H, et al. Clinical significance of CD7-positive stem cell leukemia: a distinct subtype of mixed lineage leukemia. Cancer. 1991;68:2273-2280.
22. Hurwitz CA, Raimondi SC, Head D, et al. Distinctive immunophenotypic features of t(8;21) (q22;q22) acute myeloblastic leukemia in children. Blood. 1992;80:3182-3188.
23. Reuss-Borst MA, Steinke B, Waller HD, et al. Phenotype and clinical heterogeneity of CD56-positive acute nonlymphoblastic leukemia. Ann Hematol. 1992;64:78-82.
24. Byrd JC, Weiss RB. Recurrent granulocytic sarcoma: an unusual variation of acute myelogenous leukemia associated with 8;21 chromosomal translocation and blast expression of the neural cell adhesion molecule. Cancer. 1994:73:2107-2112.
25. Vidriales MB, Orfao A, González M, et al. Expression of NK and lymphoid-associated antigens in blast cells of acute myeloblastic leukemia. Leukemia. 1993;17:2026-2029.
26. Contis L, Kaplan S. Natural killer associated antigen CD56/16 expression in acute myeloid leukemias: clinical, immunophenotypic, morphologic and cytogenetic characteristics. Am J Clin Pathol. 1994;102:545-546. Abstract.
27. Seymour JF, Pierce SA, Kantarjian HM, et al. Investigation of karyotypic, morphologic and clinical features in patients with acute myeloid leukemia blast cells expressing the neural cell adhesion molecule (CD56). Leukemia. 1994;8:823-826.
28. Borowitz MJ, Guenther KL, Shults KE, Stelzer GT. Immunophenotyping of acute leukemia by flow cytometric analysis. Am J Clin Pathol 1993;100:534-540.
29. Mitelman F, ed. Guidelines for Cancer Cytogenetics. Supplement to an International System for Human Cytogenetic Nomenclature. Basel, Switzerland: S Karger, 1991.
30. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
31. Cunningham BA, Hemperly JJ, Murray BA, Prediger EA, Brackenbury R, Edelman GM. Neural cell adhesion molecule: structure, immunoglobulin-like domains, cell surface modulation, and alternative RNA splicing. Science. 1987;236:799-806.
32. Grzeschik K-H, Kazazian HH. Report of the committee on the genetic constitution of chromosomes 10, 11, and 12. Eighth International Workshop of Human Gene Mapping. Cytogenet Cell Genet. 1985;40:191-192.
33. Lanza F, Bi S, Castoldi G, Goldman JM. Abnormal expression of N-CAM (CD56) adhesion molecule on myeloid and progenitor cells from chronic myeloid leukemia. Leukemia. 1993;7:1570-1575.
34. Caligiuri MA, Schichman SA, Strout MP, et al. Molecular rearrangement of the ALL-1 gene in acute myeloid leukemia without cytogenetic evidence of 11q23 chromosomal translocations. Cancer Res. 1994;54:370-373.
35. Lo Coco F, Mandelli F, Breccia M, et al. Southern blot analysis of ALL-1 rearrangements at chromosome 11q23 in acute leukemia. Cancer Res. 1993;53:3800-3803.
36. Cimino G, Rapanotti MC, Elia L, et al. ALL-1 gene rearrangements in acute myeloid leukemia: association with M4-M5 French-American-British classification subtypes and young age. Cancer Res. 1995;55:1625-1628.
37. Hunger SP, Tkachuk DC, Amylon MD, et al. HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalities. Blood. 1993;12:3197-3203.